思泰瑞医疗 2025年度报告

2026 Annual ReportAnnual Report on Form 10-K United States Securities and Exchange Commission Washington, D. C. 20549________________________________________________ FORM 10-K (Mark One) OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number001-38848 STERIS plc (Exact name of registrant as specified in its charter) SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT: SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.Yesx NooIndicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.Yeso NoxIndicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities ExchangeAct of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has beensubject to such filing requirements for the past 90 days.Yesx NooIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant wasrequired to submit such files). Yesx NooIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filerxAccelerated filerNon-accelerated fileroSmaller reporting companyEmerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complyingwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.oIndicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered publicaccounting firm that prepared or issued its audit report.If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.oIndicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).oIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).YesNo x The aggregate market value of Ordinary Shares held by non-affiliates of the registrant as of September 30, 2025 was $24,222.3 million.The number of Ordinary Shares outstanding as of May 27, 2026: 97,602,485 Table of Contents Part IItem 1Business3Introduction3Information Related to Business Segments3Information with Respect to Our Business in General4Item 1ARisk Factors13Item 1BUnresolved Staff Comments25Item 1CCybersecurity25Item 2Properties26Item 3Legal Proceedings27Item 4Mine Safety Disclosures27Part IIItem 5Market for Registrant's Ordinary Equity, Related Shareholder Matters and Issuer Purchases of EquitySecurities28Item 6Reserved29Item 7Management's Discussion and Analysis of Financial Condition and Results of Operation30Introduction30Financial Measures30Revenues-Defined31General Overview and Executive Summary31Non-GAAP Financial Measures33Results of Operations33Liquidity and Capital Resources39Capital Expenditures42Material Future Cash Obligations and Commercial Commitments42Supplemental Guarantor Financial Information43Critical Accounting Estimates and Assumptions45Forward-Looking Statements49Item 7AQuantitative and Qualitative Disclosures About Market Risk50Interest Rate Risk50Foreign Currency Risk50Commodity Risk50Item 8Financial Statements and Supplementary Data51Item 9Changes in and Disagreements with Accountants on Accounting and Financial Disclosure102Item 9AControls and Procedures102Item 9BOther Information104Item 9CDisclosure Regarding Foreign Jurisdictions That Prevent Inspections104Part IIIItem 10Directors, Executive Officers and Corporate Governance105Item 11Executive Compensation105Item 12Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters105Item 13Certain Relationships and Related Transactions, and Director Independence105Item 14Principal Accountant Fees and Services105Part IVItem 15Exhibits an